Curis Lifesciences Ltd (CURIS) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

61.0 k (87.12%) Volume

Shareholding (Oct 2025)

FII

0.00%

Held by 0 FIIs

DII

7.32%

Held by 0 DIIs

Promoter

92.68%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 93 Cr (Micro Cap)

P/E

15.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.94

Return on Equity

37.65%

Price to Book

5.74

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

5.89

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

26.12%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

13.79%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

5.74

EV to EBIT

12.24

EV to EBITDA

11.38

EV to Capital Employed

3.44

EV to Sales

2.21

PEG Ratio

Dividend Yield

ROCE (Latest)

28.09%

ROE (Latest)

37.65%

Technicals key factors

Indicator

Weekly

Monthly

No records

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Oct 2025

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Pawasia Siddhant J (19.05%)

Highest Public shareholder

Strategic Sixth Sense Capital Fund (2.04%)

Individual Investors Holdings

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Curis Lifescien."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Curis Lifescien."
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Curis Lifescien."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Curis Lifescien."
  }
]

Company CV

About Curis Lifesciences Ltd

Curis Lifesciences Ltd

Micro Cap

Pharmaceuticals & Biotechnology

Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of "M/s Loreto Pharmaceutacals", pursuant to a Deed of Partnership dated 2 June, 2010. Thereafter " M/s Loreto Pharmaceutacals" was converted from Partnership Firm to a Private Limited Company as "Curis Lifesciences Private Limited" and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad.

Company Coordinates

No Company Details Available